Global Epigenomic Market 2018 - by Manufacturers, Regions, Type, Application, Sales, Revenue, and Forecast to 2025

  • Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.
    In 2017, the global Epigenomic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
    
    This report focuses on the global Epigenomic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epigenomic development in United States, Europe and China.
    
    The key players covered in this study
        Roche Diagnostics
        Thermo Fisher Scientific
        Eisai
        Novartis
        ...
    
    Market segment by Type, the product can be split into
        Reagents
        Kits
        Instruments
        Enzymes
        Services
    
    Market segment by Application, split into
        Oncology
        Non Oncology
    
    Market segment by Regions/Countries, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India
        Central & South America
    
    The study objectives of this report are:
        To analyze global Epigenomic status, future forecast, growth opportunity, key market and key players.
        To present the Epigenomic development in United States, Europe and China.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by product type, market and key regions.
    
    In this study, the years considered to estimate the market size of Epigenomic are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • 
    1 Report Overview
        1.1 Study Scope
        1.2 Key Market Segments
        1.3 Players Covered
        1.4 Market Analysis by Type
            1.4.1 Global Epigenomic Market Size Growth Rate by Type (2013-2025)
            1.4.2 Reagents
            1.4.3 Kits
            1.4.4 Instruments
            1.4.5 Enzymes
            1.4.6 Services
        1.5 Market by Application
            1.5.1 Global Epigenomic Market Share by Application (2013-2025)
            1.5.2 Oncology
            1.5.3 Non Oncology
        1.6 Study Objectives
        1.7 Years Considered
    
    2 Global Growth Trends
        2.1 Epigenomic Market Size
        2.2 Epigenomic Growth Trends by Regions
            2.2.1 Epigenomic Market Size by Regions (2013-2025)
            2.2.2 Epigenomic Market Share by Regions (2013-2018)
        2.3 Industry Trends
            2.3.1 Market Top Trends
            2.3.2 Market Drivers
            2.3.3 Market Opportunities
    
    3 Market Share by Key Players
        3.1 Epigenomic Market Size by Manufacturers
            3.1.1 Global Epigenomic Revenue by Manufacturers (2013-2018)
            3.1.2 Global Epigenomic Revenue Market Share by Manufacturers (2013-2018)
            3.1.3 Global Epigenomic Market Concentration Ratio (CR5 and HHI)
        3.2 Epigenomic Key Players Head office and Area Served
        3.3 Key Players Epigenomic Product/Solution/Service
        3.4 Date of Enter into Epigenomic Market
        3.5 Mergers & Acquisitions, Expansion Plans
    
    4 Breakdown Data by Type and Application
        4.1 Global Epigenomic Market Size by Type (2013-2018)
        4.2 Global Epigenomic Market Size by Application (2013-2018)
    
    5 United States
        5.1 United States Epigenomic Market Size (2013-2018)
        5.2 Epigenomic Key Players in United States
        5.3 United States Epigenomic Market Size by Type
        5.4 United States Epigenomic Market Size by Application
    
    6 Europe
        6.1 Europe Epigenomic Market Size (2013-2018)
        6.2 Epigenomic Key Players in Europe
        6.3 Europe Epigenomic Market Size by Type
        6.4 Europe Epigenomic Market Size by Application
    
    7 China
        7.1 China Epigenomic Market Size (2013-2018)
        7.2 Epigenomic Key Players in China
        7.3 China Epigenomic Market Size by Type
        7.4 China Epigenomic Market Size by Application
    
    8 Japan
        8.1 Japan Epigenomic Market Size (2013-2018)
        8.2 Epigenomic Key Players in Japan
        8.3 Japan Epigenomic Market Size by Type
        8.4 Japan Epigenomic Market Size by Application
    
    9 Southeast Asia
        9.1 Southeast Asia Epigenomic Market Size (2013-2018)
        9.2 Epigenomic Key Players in Southeast Asia
        9.3 Southeast Asia Epigenomic Market Size by Type
        9.4 Southeast Asia Epigenomic Market Size by Application
    
    10 India
        10.1 India Epigenomic Market Size (2013-2018)
        10.2 Epigenomic Key Players in India
        10.3 India Epigenomic Market Size by Type
        10.4 India Epigenomic Market Size by Application
    
    11 Central & South America
        11.1 Central & South America Epigenomic Market Size (2013-2018)
        11.2 Epigenomic Key Players in Central & South America
        11.3 Central & South America Epigenomic Market Size by Type
        11.4 Central & South America Epigenomic Market Size by Application
    
    12 International Players Profiles
        12.1 Roche Diagnostics
            12.1.1 Roche Diagnostics Company Details
            12.1.2 Company Description and Business Overview
            12.1.3 Epigenomic Introduction
            12.1.4 Roche Diagnostics Revenue in Epigenomic Business (2013-2018)
            12.1.5 Roche Diagnostics Recent Development
        12.2 Thermo Fisher Scientific
            12.2.1 Thermo Fisher Scientific Company Details
            12.2.2 Company Description and Business Overview
            12.2.3 Epigenomic Introduction
            12.2.4 Thermo Fisher Scientific Revenue in Epigenomic Business (2013-2018)
            12.2.5 Thermo Fisher Scientific Recent Development
        12.3 Eisai
            12.3.1 Eisai Company Details
            12.3.2 Company Description and Business Overview
            12.3.3 Epigenomic Introduction
            12.3.4 Eisai Revenue in Epigenomic Business (2013-2018)
            12.3.5 Eisai Recent Development
        12.4 Novartis
            12.4.1 Novartis Company Details
            12.4.2 Company Description and Business Overview
            12.4.3 Epigenomic Introduction
            12.4.4 Novartis Revenue in Epigenomic Business (2013-2018)
            12.4.5 Novartis Recent Development
    
    13 Market Forecast 2018-2025
        13.1 Market Size Forecast by Regions
        13.2 United States
        13.3 Europe
        13.4 China
        13.5 Japan
        13.6 Southeast Asia
        13.7 India
        13.8 Central & South America
        13.9 Market Size Forecast by Product (2018-2025)
        13.10 Market Size Forecast by Application (2018-2025)
    
    14 Analyst's Viewpoints/Conclusions
    
    15 Appendix
        15.1 Research Methodology
            15.1.1 Methodology/Research Approach
                15.1.1.1 Research Programs/Design
                15.1.1.2 Market Size Estimation
                12.1.1.3 Market Breakdown and Data Triangulation
            15.1.2 Data Source
                15.1.2.1 Secondary Sources
                15.1.2.2 Primary Sources
        15.2 Disclaimer
        15.3 Author Details



    List of Tables and Figures
    
        Table Epigenomic Key Market Segments
        Table Key Players Epigenomic Covered
        Table Global Epigenomic Market Size Growth Rate by Type 2013-2025 (Million US$)
        Figure Global Epigenomic Market Size Market Share by Type 2013-2025
        Figure Reagents Figures
        Table Key Players of Reagents
        Figure Kits Figures
        Table Key Players of Kits
        Figure Instruments Figures
        Table Key Players of Instruments
        Figure Enzymes Figures
        Table Key Players of Enzymes
        Figure Services Figures
        Table Key Players of Services
        Table Global Epigenomic Market Size Growth by Application 2013-2025 (Million US$)
        Figure Oncology Case Studies
        Figure Non Oncology Case Studies
        Figure Epigenomic Report Years Considered
        Table Global Epigenomic Market Size 2013-2025 (Million US$)
        Figure Global Epigenomic Market Size and Growth Rate 2013-2025 (Million US$)
        Table Global Epigenomic Market Size by Regions 2013-2025 (Million US$)
        Table Global Epigenomic Market Size by Regions 2013-2018 (Million US$)
        Table Global Epigenomic Market Share by Regions 2013-2018
        Figure Global Epigenomic Market Share by Regions 2013-2018
        Figure Global Epigenomic Market Share by Regions 2018
        Table Market Top Trends
        Table Global Epigenomic Revenue by Manufacturers (2013-2018) (Million US$)
        Table Global Epigenomic Market Share by Manufacturers (2013-2018)
        Figure Global Epigenomic Market Share by Manufacturers in 2018
        Table Global Epigenomic Manufacturers Market Concentration Ratio (CR5 and HHI)
        Table Key Players Head office and Area Served
        Table Key Players Epigenomic Product/Solution/Service
        Table Date of Enter into Epigenomic Market
        Table Mergers & Acquisitions, Expansion Plans
        Table Global Epigenomic Market Size by Type (2013-2018) (Million US$)
        Table Global Epigenomic Market Size Share by Type (2013-2018)
        Figure Global Epigenomic Market Size Market Share by Type (2013-2018)
        Table Global Epigenomic Market Size by Application (2013-2018) (Million US$)
        Table Global Epigenomic Market Size Share by Application (2013-2018)
        Figure Global Epigenomic Market Size Market Share by Application (2013-2018)
        Figure Global Epigenomic Revenue Market Share by Application in 2017
        Figure United States Epigenomic Market Size 2013-2018 (Million US$)
        Table United States Key Players Epigenomic Revenue (2017-2018) (Million US$)
        Table United States Key Players Epigenomic Market Share (2017-2018)
        Table United States Epigenomic Market Size by Type (2013-2018) (Million US$)
        Table United States Epigenomic Market Share by Type (2013-2018)
        Table United States Epigenomic Market Size by Application (2013-2018) (Million US$)
        Table United States Epigenomic Market Share by Application (2013-2018)
        Figure Europe Epigenomic Market Size 2013-2018 (Million US$)
        Table Europe Key Players Epigenomic Revenue (2017-2018) (Million US$)
        Table Europe Key Players Epigenomic Market Share (2017-2018)
        Table Europe Epigenomic Market Size by Type (2013-2018) (Million US$)
        Table Europe Epigenomic Market Share by Type (2013-2018)
        Table Europe Epigenomic Market Size by Application (2013-2018) (Million US$)
        Table Europe Epigenomic Market Share by Application (2013-2018)
        Figure China Epigenomic Market Size 2013-2018 (Million US$)
        Table China Key Players Epigenomic Revenue (2017-2018) (Million US$)
        Table China Key Players Epigenomic Market Share (2017-2018)
        Table China Epigenomic Market Size by Type (2013-2018) (Million US$)
        Table China Epigenomic Market Share by Type (2013-2018)
        Table China Epigenomic Market Size by Application (2013-2018) (Million US$)
        Table China Epigenomic Market Share by Application (2013-2018)
        Figure Japan Epigenomic Market Size 2013-2018 (Million US$)
        Table Japan Key Players Epigenomic Revenue (2017-2018) (Million US$)
        Table Japan Key Players Epigenomic Market Share (2017-2018)
        Table Japan Epigenomic Market Size by Type (2013-2018) (Million US$)
        Table Japan Epigenomic Market Share by Type (2013-2018)
        Table Japan Epigenomic Market Size by Application (2013-2018) (Million US$)
        Table Japan Epigenomic Market Share by Application (2013-2018)
        Figure Southeast Asia Epigenomic Market Size 2013-2018 (Million US$)
        Table Southeast Asia Key Players Epigenomic Revenue (2017-2018) (Million US$)
        Table Southeast Asia Key Players Epigenomic Market Share (2017-2018)
        Table Southeast Asia Epigenomic Market Size by Type (2013-2018) (Million US$)
        Table Southeast Asia Epigenomic Market Share by Type (2013-2018)
        Table Southeast Asia Epigenomic Market Size by Application (2013-2018) (Million US$)
        Table Southeast Asia Epigenomic Market Share by Application (2013-2018)
        Figure India Epigenomic Market Size 2013-2018 (Million US$)
        Table India Key Players Epigenomic Revenue (2017-2018) (Million US$)
        Table India Key Players Epigenomic Market Share (2017-2018)
        Table India Epigenomic Market Size by Type (2013-2018) (Million US$)
        Table India Epigenomic Market Share by Type (2013-2018)
        Table India Epigenomic Market Size by Application (2013-2018) (Million US$)
        Table India Epigenomic Market Share by Application (2013-2018)
        Figure Central & South America Epigenomic Market Size 2013-2018 (Million US$)
        Table Central & South America Key Players Epigenomic Revenue (2017-2018) (Million US$)
        Table Central & South America Key Players Epigenomic Market Share (2017-2018)
        Table Central & South America Epigenomic Market Size by Type (2013-2018) (Million US$)
        Table Central & South America Epigenomic Market Share by Type (2013-2018)
        Table Central & South America Epigenomic Market Size by Application (2013-2018) (Million US$)
        Table Central & South America Epigenomic Market Share by Application (2013-2018)
        Table Roche Diagnostics Company Details
        Table Roche Diagnostics Revenue in Epigenomic Business (2013-2018) (Million US$)
        Figure Roche Diagnostics Revenue Growth Rate in Epigenomic Business (2013-2018)
        Table Roche Diagnostics Recent Development
        Table Thermo Fisher Scientific Company Details
        Table Thermo Fisher Scientific Revenue in Epigenomic Business (2013-2018)(Million US$)
        Figure Thermo Fisher Scientific Revenue Growth Rate in Epigenomic Business (2013-2018)
        Table Thermo Fisher Scientific Recent Development
        Table Eisai Company Details
        Table Eisai Revenue in Epigenomic Business (2013-2018)(Million US$)
        Figure Eisai Revenue Growth Rate in Epigenomic Business (2013-2018)
        Table Eisai Recent Development
        Table Novartis Company Details
        Table Novartis Revenue in Epigenomic Business (2013-2018)(Million US$)
        Figure Novartis Revenue Growth Rate in Epigenomic Business (2013-2018)
        Table Novartis Recent Development
        Table Global Epigenomic Market Size by Regions (Million US$) 2018-2025
        Figure Global Epigenomic Market Size Share by Regions (2018-2025)
        Figure Global Epigenomic Market Size Share by Regions in 2025
        Figure United States Epigenomic Market Size Forecast (2018-2025)(Million USD)
        Figure Europe Epigenomic Market Size Forecast (2018-2025)(Million USD)
        Figure China Epigenomic Market Size Forecast (2018-2025)(Million USD)
        Figure Japan Epigenomic Market Size Forecast (2018-2025)(Million USD)
        Figure Southeast Asia Epigenomic Market Size Forecast (2018-2025)(Million USD)
        Figure India Epigenomic Market Size Forecast (2018-2025)(Million USD)
        Figure Central & South America Epigenomic Market Size Forecast (2018-2025)(Million USD)
        Table Global Epigenomic Market Size by Product (2018-2025) (Million US$)
        Figure Global Epigenomic Market Size by Product (2018-2025)
        Figure Global Epigenomic Market Size by Product in 2025
        Table Global Epigenomic Market Size by Application (2018-2025) (Million US$)
        Figure Global Epigenomic Market Size by Application (2018-2025)
        Figure Global Epigenomic Market Size by Application in 2025
        Table Research Programs/Design for This Report
        Figure Bottom-up and Top-down Approaches for This Report
        Figure Data Triangulation
        Table Key Data Information from Secondary Sources
        Table Key Data Information from Primary Sources